Informace o publikaci

Artificial intelligence in pancreatic cancer histopathology and diagnostics - implications for clinical decisions and biomarker discovery?

Autoři

WESELÁ Petra EID Michal MORAVČÍK Petr VLAŽNÝ Jakub HLAVSA Jan PROCHÁZKA Vladimír KALA Zdeněk VAŇHARA Petr

Rok publikování 2025
Druh Článek v odborném periodiku
Časopis / Zdroj Cell Division
Fakulta / Pracoviště MU

Lékařská fakulta

Citace
www https://celldiv.biomedcentral.com/articles/10.1186/s13008-025-00158-w
Doi http://dx.doi.org/10.1186/s13008-025-00158-w
Klíčová slova Artificial intelligence; Machine learning; Multimodal learning;Pancreatic cancer; Pancreatic ductal adenocarcinoma; Biomarker discovery
Přiložené soubory
Popis Artificial intelligence (AI) and machine learning (ML) are rapidly advancing fields within computer science, driving significant progress in cancer diagnostics. Various ML models have been developed to assist diagnosis, guide therapy decisions, and facilitate early disease detection. In this review, we discuss diverse AI and ML approaches and critically evaluate their applications and limitations in pancreatic cancer histopathology, diagnostics, and biomarker discovery.
Související projekty:

Používáte starou verzi internetového prohlížeče. Doporučujeme aktualizovat Váš prohlížeč na nejnovější verzi.

Další info

OSZAR »